Home » Newsletters » BioWorld Science

BioWorld Science

April 26, 2002

View Archived Issues

Bay-43-9006 discussed at AACR

Results from phase II study of IPL-576092 in asthma

Prefilled syringe presentation of Copaxone launched

Periostat approved in Austria and Finland

Pan-caspase inhibitor protects against renal ischemia/reperfusion injury

Blockade of VLA-4 together with immunosuppression may help prevent transplant vasculopathy

Data from preclinical research confirm the potential of AVI-4557 for metabolic redirection

ECCMID presentations highlight the promise of PLD-118, a novel antifungal agent

Complement inhibitor GAS-914 may protect against cytotoxic injury in xenotransplantation

Interim phase II results for ISAtx-247 in renal transplantation

Good correlation between duration of bacterial exposure to and in vivo efficacy of SB-264128

ECCMID news: antimicrobial activity and effects on intestinal microflora reported for BMS-284756

Novavax withdraws NDA for Estrasorb with plans to resubmit

Successful phase II results lead to expanded development of pralnacasan

BioCryst updates first-quarter progress

MediGene submits MAA in Germany for Eligard 22.5 mg

Altana and Pharmacia to codevelop and comarket roflumilast for respiratory conditions

Chromos and MorphoGen collaborate on stem cell technologies

Pennsaid receives approval in Europe, to be distributed in Benelux by Tramedico

Peptide derG provides protection against malaria, herpes and cancer

Idec extends IDEC-152 collaboration with Seikagaku

Factor Xa inhibitors and their use in thrombotic disorders

Pyridazine compounds claimed by Biovitrum for diabetes Rx

Pharmacia presents new integrin antagonists in patent literature

Immunomodulating and neurotrophic effects reported for 1-oxorapamycins

New 5-HT1A ligands and monoamine reuptake inhibitors and their therapeutic applications

Advanced Medicine patents sodium channel modulators

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.